Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)

NCT00116259 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder
Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Aripiprazole

Sponsor

Federal University of Rio Grande do Sul

Collaborators

[object Object]